Page last updated: 2024-10-18

glycine and Carcinoma, Epidermoid

glycine has been researched along with Carcinoma, Epidermoid in 27 studies

Research Excerpts

ExcerptRelevanceReference
"Head and neck squamous cell carcinoma (HNSCC) is characterized by high proliferation and limited differentiation."1.91p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer. ( Bernassola, F; Candi, E; Cappello, A; Ganini, C; Melino, G; Shi, Y; Smirnov, A; Tosetti, G; Wang, Y; Yang, X, 2023)
"Esophageal squamous cell carcinoma (ESCC) is one of the major subtypes of esophageal cancer."1.72Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway. ( Chen, H; Chen, L; Li, Q; Qi, H; Shi, X; Wang, T; Zhang, L; Zhang, P; Zhong, M; Zhu, Y, 2022)
"Oral cavity squamous cell carcinoma (OCC) and oropharyngeal squamous cell carcinoma (OPC) are among the most common cancers worldwide and are associated with high mortality and morbidity."1.48Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls. ( Buas, MF; Chen, C; Djukovic, D; Gu, H; Lohavanichbutr, P; Nagana Gowda, GA; Raftery, D; Wang, P; Zhang, Y, 2018)
"The importance of PIK3CA alterations in squamous cell carcinoma of the head and neck (HNSCC) has raised interest in exploring agents targeting PI3K, the product of PIK3CA."1.39The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas. ( Aisner, DL; Anderson, RT; Astling, DP; Bowles, DW; Eagles-Soukup, J; Frederick, BA; Gan, GN; Glogowska, MJ; Jimeno, A; Keysar, SB; Le, P; Morton, JJ; Sehrt, D; Takimoto, SM; Tan, AC; Umpierrez, A; Varella-Garcia, M; Vogler, BW; Wilhelm, F, 2013)
"Nine specimens of well-differentiated squamous cell carcinoma of the lip vermilion have been analyzed for the presence of H-ras oncogene mutations, using the technique of hybridization with synthetic oligonucleotide probes on in vitro amplified tumour DNA."1.29High incidence of H-ras oncogene mutations in squamous cell carcinoma of lip vermilion. ( Dedović, N; Dimitrijević, B; Milasin, J; Nikolić, Z; Petrović, V; Pujić, N, 1994)
"57 primary tumour samples from Indian oral cancer patients with a 5-15 year tobacco chewing habit, were examined for mutational activation in codons 12, 13 and 61 of the H-ras, K-ras and N-ras oncogenes."1.28High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. ( Bhoite, LT; Chang, SE; Deo, MG; Johnson, NW; Kerr, IB; Mehta, AR; Panchal, RG; Saranath, D, 1991)

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19904 (14.81)18.7374
1990's7 (25.93)18.2507
2000's5 (18.52)29.6817
2010's7 (25.93)24.3611
2020's4 (14.81)2.80

Authors

AuthorsStudies
Wang, T1
Zhang, P1
Chen, L1
Qi, H1
Chen, H2
Zhu, Y1
Zhang, L1
Zhong, M1
Shi, X1
Li, Q1
Cappello, A1
Tosetti, G1
Smirnov, A1
Ganini, C1
Yang, X2
Shi, Y2
Wang, Y1
Melino, G1
Bernassola, F1
Candi, E1
Kim, HS1
Hammill, JT1
Scott, DC1
Chen, Y1
Min, J1
Rector, J1
Singh, B1
Schulman, BA1
Guy, RK1
Gil, S1
Solano, E1
Martínez-Trucharte, F1
Martínez-Esaín, J1
Pérez-Berná, AJ1
Conesa, JJ1
Kamma-Lorger, C1
Alsina, M1
Sabés, M1
Zagefka, H1
Huynh, HP1
Senger, AR1
Derington, CG1
Colantonio, LD1
Herrick, JS1
Cook, J1
King, JB1
Rosenson, RS1
Poudel, B1
Monda, KL1
Navar, AM1
Mues, KE1
Stevens, VW1
Nelson, RE1
Vanneman, ME1
Muntner, P1
Bress, AP1
Ma, B1
Ren, G1
Xu, J1
Yin, C1
Rahsepar, AA1
Bluemke, DA1
Habibi, M1
Liu, K1
Kawel-Boehm, N1
Ambale-Venkatesh, B1
Fernandes, VRS1
Rosen, BD1
Lima, JAC1
Carr, JC1
Freitag, TM1
Chen-Sankey, JC1
Duarte, DA1
Ramsey, MW1
Choi, K1
Winkler-Heil, R1
Hussain, M1
Hofmann, W1
Nicotera, AG1
Dicanio, D1
Pironti, E1
Bonsignore, M1
Cafeo, A1
Efthymiou, S1
Mondello, P1
Salpietro, V1
Houlden, H1
Di Rosa, G1
Hayes-Ryan, D1
O'Donoghue, K1
McCarthy, C1
Totorika, A1
Meaney, S1
Pang, RD1
Dormanesh, A1
Hoang, Y1
Chu, M1
Allem, JP1
Girón-Ortega, JA1
Márquez-Coello, M1
Gutiérrez-Saborido, D1
Arizcorreta, A1
Cuesta-Sancho, S1
Girón-González, JA1
Dovrat, G1
Pevzner, S1
Berthon, C1
Lerner, A1
Maimon, E1
Vainer, R1
Karpasas, M1
Ben-Elyiahu, Y1
Moisy, P1
Bettelheim, A1
Zilbermann, I1
Vanden Broeck, SMP1
Nelson, DJ1
Collado, A1
Falivene, L1
Cavallo, L1
Cordes, DB1
Slawin, AMZ1
Van Hecke, K1
Nahra, F1
Cazin, CSJ1
Nolan, SP1
Kranidiotis-Hisatomi, N1
Yi, H1
Oestreich, M1
Kwiezinski, C1
Weller, C1
van Pinxteren, D1
Brüggemann, M1
Mertes, S1
Stratmann, F1
Herrmann, H1
Treggiari, D1
Tridello, G1
Menin, L1
Borruso, A1
Pintani, E1
Iansa, P1
Cipolli, M1
Melotti, P1
Ren, L1
Liu, L3
Shu, X1
Lin, W1
Yang, P1
Chen, J1
Teo, KL1
Xiao, F1
Wang, H1
Yao, T1
Zhao, X1
Yu, DYW1
Rogach, AL1
Bordet, A1
Leitner, W1
Gao, S1
Xia, F1
Li, B2
Abdul Razak, IB1
Liu, Y1
Lu, K1
Brown, DE1
Wang, R1
Cheng, Y1
Ni, S1
Qu, H1
Xing, H1
Xu, Z1
Zhu, X1
Yuan, M1
Wang, L1
Yu, J1
Li, Y1
Yang, L1
Liu, H1
Cao, L1
Zhang, S1
Zhao, D1
Yan, T1
Yang, G1
Lin, Z1
Luo, M1
Ye, N1
Lee, SW1
Carnicelli, J1
Getya, D1
Gitsov, I1
Phillips, KS1
Ren, D1
Grützmacher, PG1
Suarez, S1
Tolosa, A1
Gachot, C1
Song, G1
Wang, B1
Presser, V1
Mücklich, F1
Anasori, B1
Rosenkranz, A1
Demireva, M1
Armentrout, PB1
Feng, D1
Cao, K1
He, ZZ1
Knibbs, LD1
Jalaludin, B1
Leskinen, A1
Roponen, M1
Komppula, M1
Jalava, P1
Guo, PY1
Xu, SL1
Yang, BY1
Hu, L1
Zeng, XW1
Chen, G1
Yu, HY1
Lin, L1
Dong, G1
Machulkin, AE1
Shafikov, RR1
Uspenskaya, AA1
Petrov, SA1
Ber, AP1
Skvortsov, DA1
Nimenko, EA1
Zyk, NU1
Smirnova, GB1
Pokrovsky, VS1
Abakumov, MA1
Saltykova, IV1
Akhmirov, RT1
Garanina, AS1
Polshakov, VI1
Saveliev, OY1
Ivanenkov, YA1
Aladinskaya, AV1
Finko, AV1
Yamansarov, EU1
Krasnovskaya, OO1
Erofeev, AS1
Gorelkin, PV1
Dontsova, OA1
Beloglazkina, EK1
Zyk, NV1
Khazanova, ES1
Majouga, AG1
Zheng, YK1
Su, BJ1
Wang, YQ1
Wang, HS1
Liao, HB1
Liang, D1
Shataer, D1
Li, J1
Duan, XM1
Xin, XL1
Aisa, HA1
Allu, SR1
Ravotto, L1
Troxler, T1
Vinogradov, SA1
Cheruku, RR1
Tracy, EC1
Tabaczynski, W1
Missert, JR1
Baumann, H1
Pandey, RK1
Rohde, JM1
Karavadhi, S1
Pragani, R1
Fang, Y1
Zhang, W1
McIver, A1
Zheng, H1
Liu, Q1
Davis, MI1
Urban, DJ1
Lee, TD1
Cheff, DM1
Hollingshead, M1
Henderson, MJ1
Martinez, NJ1
Brimacombe, KR1
Yasgar, A1
Zhao, W1
Klumpp-Thomas, C1
Michael, S1
Covey, J1
Moore, WJ1
Stott, GM1
Li, Z1
Simeonov, A1
Jadhav, A1
Frye, S1
Hall, MD1
Shen, M1
Wang, X1
Patnaik, S1
Boxer, MB1
Zhang, H2
Cheng, C1
Huang, B1
Chen, R1
Huang, Y1
Pei, W1
Katahara, S1
Sugiyama, Y1
Yamane, M1
Komiya, Y1
Sato, T1
Chida, N1
Momcilovic, M1
Bailey, ST1
Lee, JT1
Fishbein, MC1
Braas, D1
Go, J1
Graeber, TG1
Parlati, F1
Demo, S1
Li, R1
Walser, TC1
Gricowski, M1
Shuman, R1
Ibarra, J1
Fridman, D1
Phelps, ME1
Badran, K1
St John, M1
Bernthal, NM1
Federman, N1
Yanagawa, J1
Dubinett, SM1
Sadeghi, S1
Christofk, HR1
Shackelford, DB1
Lohavanichbutr, P1
Zhang, Y1
Wang, P1
Gu, H1
Nagana Gowda, GA1
Djukovic, D1
Buas, MF1
Raftery, D1
Chen, C1
Atanasova, VS1
Pourreyron, C1
Farshchian, M1
Lawler, M1
Brown, CA1
Watt, SA1
Wright, S1
Warkala, M1
Guttmann-Gruber, C1
Hofbauer, JP1
Fuentes, I1
Prisco, M1
Rashidghamat, E1
Has, C1
Salas-Alanis, JC1
Palisson, F1
Hovnanian, A1
McGrath, JA1
Mellerio, JE1
Bauer, JW1
South, AP1
Anderson, RT1
Keysar, SB1
Bowles, DW1
Glogowska, MJ1
Astling, DP1
Morton, JJ1
Le, P1
Umpierrez, A1
Eagles-Soukup, J1
Gan, GN1
Vogler, BW1
Sehrt, D1
Takimoto, SM1
Aisner, DL1
Wilhelm, F1
Frederick, BA1
Varella-Garcia, M1
Tan, AC1
Jimeno, A1
Yunlong, B1
Hao, H1
Kai, Y1
Hong, T1
Prasad, A1
Khudaynazar, N1
Tantravahi, RV1
Gillum, AM1
Hoffman, BS1
Motoyama, S1
Miura, M1
Hinai, Y1
Maruyama, K1
Usami, S1
Nakatsu, T1
Saito, H1
Minamiya, Y1
Suzuki, T1
Ogawa, J1
BENNETT, LL2
SMITHERS, D2
WARD, CT1
PAN, JC1
HO, S1
CHEN, CK1
BAI, YC1
BROCKMAN, RW2
CHUMLEY, S1
Koh, TJ1
Field, JK1
Varro, A1
Liloglou, T1
Fielding, P1
Cui, G1
Houghton, J1
Dockray, GJ1
Wang, TC1
Murphy, KT1
Wardak, A1
Beckett, MA1
Lopez, CA1
Mehta, N1
Kimchi, E1
Salloum, RM1
Jaskowiak, NT1
Posner, MC1
Ohno, T1
Kufe, DW1
Weichselbaum, RR1
Mauceri, HJ1
Rose, LM1
Adamson, DJ1
Milasin, J1
Pujić, N1
Dedović, N1
Nikolić, Z1
Petrović, V1
Dimitrijević, B1
Richards, EW1
Long, CL1
Nelson, KM1
Tohver, OK1
Pinkston, JA1
Navari, RM1
Blakemore, WS1
Inada, M1
Yamashita, J1
Ogawa, M2
Matsumura, F1
Yamaguchi, Y1
Ralhan, R1
Agarwal, S1
Mathur, M1
Wasylyk, B1
Srivastava, A1
Keadle, DM1
Light, D1
Bauman, JM1
Isoai, A1
Ueno, Y1
Giga-Hama, Y1
Goto, H1
Kumagai, H1
Warnakulasuriya, KA1
Chang, SE2
Johnson, NW2
Saranath, D1
Bhoite, LT1
Panchal, RG1
Kerr, IB1
Mehta, AR1
Deo, MG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma[NCT01807546]Phase 264 participants (Actual)Interventional2013-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

27 other studies available for glycine and Carcinoma, Epidermoid

ArticleYear
Ixazomib Induces Apoptosis and Suppresses Proliferation in Esophageal Squamous Cell Carcinoma through Activation of the c-Myc/NOXA Pathway.
    The Journal of pharmacology and experimental therapeutics, 2022, Volume: 380, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Boron Compounds; Carcinoma, Squamous Cell; Cell Line, Tum

2022
p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer.
    Biology direct, 2023, Nov-09, Volume: 18, Issue:1

    Topics: Carbon; Carcinoma, Squamous Cell; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glycine;

2023
Discovery of Novel Pyrazolo-pyridone DCN1 Inhibitors Controlling Cullin Neddylation.
    Journal of medicinal chemistry, 2019, 09-26, Volume: 62, Issue:18

    Topics: Amides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cullin Proteins; Cyclopentan

2019
Multiparametric analysis of the effectiveness of cisplatin on cutaneous squamous carcinoma cells using two different types of adjuvants.
    PloS one, 2020, Volume: 15, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Size; Chelating A

2020
    Journal of applied social psychology, 2021, Volume: 51, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Animals; Anti-Bacterial Agents; Anti-

2021
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
    Cancer cell, 2018, 05-14, Volume: 33, Issue:5

    Topics: Animals; Benzeneacetamides; Boron Compounds; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Prolif

2018
Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls.
    PloS one, 2018, Volume: 13, Issue:9

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chromatography, Liquid; Citrulline; Early

2018
Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2019, 06-01, Volume: 25, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Proteins; Epidermolysis Bullo

2019
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:10

    Topics: Carcinoma, Squamous Cell; Cell Cycle Proteins; Class I Phosphatidylinositol 3-Kinases; Glycine; Head

2013
[In situ visual imaging of oral squamous cell carcinoma in mice by using near-infrared quantum dots conjugated with arginine-glycine-aspartic acid peptide fluorescent probes].
    Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology, 2014, Volume: 32, Issue:5

    Topics: Animals; Arginine; Aspartic Acid; Carcinoma, Squamous Cell; Cell Line, Tumor; Fluorescent Dyes; Glyc

2014
ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines.
    Oncotarget, 2016, Nov-29, Volume: 7, Issue:48

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival

2016
C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
    Journal of the American College of Surgeons, 2009, Volume: 209, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; C-Reactive Protein; Carcinoma, Squamous Cell; Cys

2009
INHIBITION OF DNA SYNTHESIS IN MAMMALIAN CELLS BY ACTIDIONE.
    Biochimica et biophysica acta, 1964, May-18, Volume: 87

    Topics: Adenine; Adenine Nucleotides; Anti-Bacterial Agents; Aspartic Acid; Carbon Isotopes; Carcinoma, Squa

1964
THE ALTERATIONS OF NORMAL HUMAN EMBRYONIC CELL STRAINS AFTER CONTINUOUS CULTIVATION IN VITRO AND THEIR COMPARISON WITH CELL STRAINS OF TUMOR ORIGIN.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Amino Acids; Carcinoma, Squamous Cell; Fetus; Fibroblasts; Glycine; Histocytochemistry; In Vitro Tec

1964
INHIBITION OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE SYNTHESIS IN NEOPLASTIC CELLS BY PURINES AND ANALOGS.
    Biochimica et biophysica acta, 1965, Mar-15, Volume: 95

    Topics: Adenine; Animals; Antimetabolites; Antineoplastic Agents; Azaserine; Carcinoma, Squamous Cell; Glyci

1965
Glycine-extended gastrin promotes the growth of lung cancer.
    Cancer research, 2004, Jan-01, Volume: 64, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma,

2004
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
    Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality

2005
Mode of action of 2-amino-6-chloro-1-deazapurine.
    Biochemical pharmacology, 1984, Jan-15, Volume: 33, Issue:2

    Topics: 2-Aminopurine; Adenine; AMP Deaminase; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cel

1984
High incidence of H-ras oncogene mutations in squamous cell carcinoma of lip vermilion.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1994, Volume: 23, Issue:7

    Topics: Aged; Aged, 80 and over; Base Sequence; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Genes, ras;

1994
Protein turnover in advanced lung cancer patients.
    Metabolism: clinical and experimental, 1993, Volume: 42, Issue:3

    Topics: Adenocarcinoma; Aged; Blood Urea Nitrogen; Body Mass Index; Body Weight; Calorimetry; Carcinoma, Squ

1993
Neutrophil elastase inhibitor (ONO-5046-Na) inhibits the growth of human lung cancer cell lines transplanted into severe combined immunodeficiency (scid) mice.
    Research communications in molecular pathology and pharmacology, 1997, Volume: 97, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous

1997
Adhesion molecule expression in vascular endothelial cells incubated with cancer cell line supernatant are inhibited by neutrophil elastase inhibitor (ONO-5046.Na).
    Research communications in molecular pathology and pharmacology, 1997, Volume: 98, Issue:1

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Endothelium, Vascular; Glycine; H

1997
Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:6

    Topics: Adult; Aged; Alleles; Antibodies, Monoclonal; Apoptosis; Aspartic Acid; Carcinoma, Squamous Cell; Ce

2000
Mesenteric varices mimicking right lower quadrant inflammation on hepatobiliary imaging.
    Clinical nuclear medicine, 2001, Volume: 26, Issue:6

    Topics: Abdomen; Abdominal Pain; Aniline Compounds; Appendicitis; Carcinoma, Squamous Cell; Diagnosis, Diffe

2001
A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis.
    Cancer letters, 1992, Aug-31, Volume: 65, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Arginine; Aspartic Acid; Carcinoma, Squamous Cell; Cell Adhesion;

1992
Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 1992, Volume: 21, Issue:5

    Topics: Carcinoma, Squamous Cell; Codon; DNA Probes; DNA, Neoplasm; Female; Gene Amplification; Genes, ras;

1992
High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India.
    British journal of cancer, 1991, Volume: 63, Issue:4

    Topics: Adult; Aged; Alleles; Base Sequence; Carcinoma, Squamous Cell; Codon; DNA, Neoplasm; Female; Genes,

1991